Land: USA
Språk: engelsk
Kilde: NLM (National Library of Medicine)
BACLOFEN (UNII: H789N3FKE8) (BACLOFEN - UNII:H789N3FKE8)
Asclemed USA, Inc.
ORAL
PRESCRIPTION DRUG
Baclofen tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Patients should have reversible spasticity so that baclofen tablets treatment will aid in restoring residual function. Baclofen tablets may also be of some value in patients with spinal cord injuries and other spinal cord diseases. Baclofen tablets are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. The efficacy of baclofen in stroke, cerebral palsy, and Parkinson’s disease has not been established and, therefore, it is not recommended for these conditions. Hypersensitivity to baclofen.
Baclofen Tablets USP, 10 mg are white to off-white, round, flat-faced, beveled-edge scored tablet debossed with “B” above score line and “10” below score line on one side and plain on other side. They are supplied as follows: Bottles of 30 NDC 76420-241-30 (repackaged from NDC 59651-394-XX) Bottles of 60 NDC 76420-241-60 (repackaged from NDC 59651-394-XX) Bottles of 90 NDC 76420-241-90 (repackaged from NDC 59651-394-XX) Baclofen Tablets USP, 20 mg are white to off-white, round, flat-faced, beveled-edge scored tablet debossed with “B” above score line and “20” below score line on one side and plain on other side. They are supplied as follows: Bottles of 30 NDC 76420-242-30 (repackaged from NDC 59651-395-XX) Bottles of 60 NDC 76420-242-60 (repackaged from NDC 59651-395-XX) Bottles of 90 NDC 76420-242-90 (repackaged from NDC 59651-395-XX) Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a well-closed container as defined in the USP, with a child-resistant closure (as required). Repackaged by: Enovachem PHARMACEUTICALS Torrance, CA 90501
Abbreviated New Drug Application
BACLOFEN - BACLOFEN TABLET ASCLEMED USA, INC. ---------- BACLOFEN TABLETS USP RX ONLY DESCRIPTION Baclofen USP, is a muscle relaxant and antispastic, available as 10 mg and 20 mg tablets for oral administration. Its chemical name is 4-amino-3-(4-chlorophenyl)- butanoic acid, and its structural formula is Baclofen USP is a white to off-white crystalline powder, with a molecular weight of 213.66. It is slightly soluble in water, very slightly soluble in methanol and in 96% ethanol, practically insoluble in acetone, insoluble in chloroform, dissolves in dilute mineral acids and in dilute solutions of alkali hydroxides. _Inactive Ingredients. _Colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose and pregelatinized starch (maize). FDA approved dissolution test specifications differ from USP. CLINICAL PHARMACOLOGY The precise mechanism of action of baclofen is not fully known. Baclofen is capable of inhibiting both monosynaptic and polysynaptic reflexes at the spinal level, possibly by hyperpolarization of afferent terminals, although actions at supraspinal sites may also occur and contribute to its clinical effect. Although baclofen is an analog of the putative inhibitory neurotransmitter gamma-aminobutyric acid (GABA), there is no conclusive evidence that actions on GABA systems are involved in the production of its clinical effects. In studies with animals, baclofen has been shown to have general CNS depressant properties as indicated by the production of sedation with tolerance, somnolence, ataxia, and respiratory and cardiovascular depression. Baclofen is rapidly and extensively absorbed and eliminated. Absorption may be dose-dependent, being reduced with increasing doses. Baclofen is excreted primarily by the kidney in unchanged form and there is relatively large intersubject variation in absorption and/or elimination. INDICATIONS AND USAGE Baclofen tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flex Les hele dokumentet